ליטפולו 50 מ"ג - Litfulo 50 mg
× ×ª×× × ×ª×¨×פ×
×××¨×©× 
| ק×××¦× ×¤×¨×ק×××××ת (ATC4) | L04AF Janus-associated kinase (JAK) inhibitors | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ×ר××× ×¤×¢×× (ATC5) | Â
| |||||||||||||
| צ×רת ××ª× | פ××× - PER OS | |||||||||||||
| צ×רת ××× ×× | קפס×××ת, CAPSULES ××× ×עת ××× ×× ×תר ×× ×רע×× ×ש ××××× ×ת ×תר××¤× ××ת×× ×××× ×× ××××××¥ ××¤× ×©××פ××¢ ××¢××× ×צר×× | |||||||||||||
| ×ת×××× | LITFULO is a kinase inhibitor indicated for the treatment of severe alopecia areata in adults and adolescents 12 years and older.Limitations of Use: Not recommended for use in combination with other JAK inhibitors, biologicimmunomodulators, cyclosporine or other potent immunosuppressants | |||||||||||||
| ||||||||||||||
| ×ת××ת ××× ×× | Posology and method of administration | |||||||||||||
| ×ת××××ת × ×× | Contraindications | |||||||||||||
| ת×פע×ת ××××× | Undesirable effects | |||||||||||||
| ת××××ת ××× ×ª×¨×פת××ת | Interaction with other medicinal products and other forms of interaction | |||||||||||||
| ש×××ש ×××ר××× ××× ×§× | Pregnancy and Lactation | |||||||||||||
| פר×ק×××× ×××§× | Pharmacodynamic Properties | |||||||||||||
| ×¢××× ×ר××¤× ××××ר×ת ××¢××× |
  | |||||||||||||
| ×¢××× ×צר×× |  |
|---|
| ער××× ××××ק×רפ××× | ער××× ×§×©×ר×× ××××ק×רפ××× |
|---|---|
| ×××פ××× 50 ×"× ××××ר ××©×¨× ××ר×××ת |
| ××פ×ש ×××ר×× | ×××ר×× ×-PubMed |
|---|---|
| ××××¢ ×רשת | RxList WebMD Drugs.com |
| ×©× ××¦×¨× | PFIZER INC., USA |
| ×©× ××¢× ×ר×ש×× | PFIZER PHARMACEUTICALS ISRAEL LTD |
| ר×ש××× | ת×ר×× ××ש×: 7/2023. ר×ש××× ×ת×ר××: |
| ת×ר×× ×¢×××× ××ר×× | 04/08/2024 |
השינוי האחרון נעשה בֹ־2 באוגוסט 2025 ב־23:16